For more information or confidential assistance
se habla español

Xarelto MDL Continues to Grow

xarelto pill bottle
The Xarelto multidistrict litigation in Louisiana continues to grow, as another lawsuit was added to the ongoing proceedings on February 11. Estella Roethler filed a lawsuit individually and as the representative of the estate of Augustina Asocar Rodriguez. Rodriguez was prescribed and ingested the blood thinning medication from approximately January... Read more »

Study Suggests Xarelto Presents Greater Risk for Kidney Patients

According to recently-released research findings, next-generation blood-thinning drug Xarelto may pose additional risk to patients who are already suffering from kidney disease. The study, based on data taken from the Department of Defense electronic medical records system, found that those with existing kidney ailments were significantly more likely to experience... Read more »

FDA Approval of Xarelto May Have Been Based on False Data

xarelto pill bottle
Thousands of Xarelto users have brought federal lawsuits against the drug’s manufacturers alleging that the anticoagulant caused uncontrollable bleeding and severe injuries. Recent reports shed light on a how the drug made it to the market with FDA approval. The anticoagulant’s drug trial was based on what may have been a... Read more »

Several Claims Added to Xarelto MDL

xarelto pill bottle
On December 2, 2015, six additional claimants added their causes of action to the pending multidistrict litigation (MDL) involving the blood-thinning drug Xarelto. Xarelto, which is also known rivaroxaban, is a relatively new blood thinning drug touted to offer patients an increased level of convenience as they treat their underlying... Read more »